发明名称 SUSTAINED RELEASE CANNABINOID MEDICAMENTS
摘要 The present invention provides a medicament which results in delivery of a therapeutic level of one or more cannabinoids during a clinically relevant therapeutic window. The therapeutic window is a longer window than provided by an immediate release medicament such as Marinol containing an equivalent amount of the cannabinoid. Oral administration of the present compositions provides therapeutic dosing while maintaining safe, side effect sparing, levels of a cannabinoid. The present invention also provides methods of treating cannabinoid-sensitive disorders.
申请公布号 US2012231083(A1) 申请公布日期 2012.09.13
申请号 US201213474666 申请日期 2012.05.17
申请人 CARLEY DAVID;FEDDE KENTON;KOLENG JOHN;LETENDRE PETER;THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS;PIER PHARMACEUTICALS 发明人 CARLEY DAVID;FEDDE KENTON;KOLENG JOHN;LETENDRE PETER
分类号 A61K9/14;A61K31/352;A61P11/00 主分类号 A61K9/14
代理机构 代理人
主权项
地址